Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Amgen Inc (NASDAQ:AMGN)

160.41
Delayed Data
As of Apr 21
 -1.63 / -1.01%
Today’s Change
133.64
Today|||52-Week Range
184.21
+9.71%
Year-to-Date

Today’s Trading

Previous close162.04
Today’s open162.15
Day’s range160.25 - 162.73
Volume2,906,923
Average volume (3 months)3,672,076
Market cap$118.0B
Dividend yield2.87%
Data as of 3:59pm ET, 04/21/2017

Growth & Valuation

Earnings growth (last year)+13.02%
Earnings growth (this year)+5.55%
Earnings growth (next 5 years)+6.44%
Revenue growth (last year)+6.31%
P/E ratio15.7
Price/Sales4.86
Price/Book3.96

Competitors

 Today’s
change
Today’s
% change
GILDGilead Sciences-0.57-0.86%
BIIBBiogen+0.48+0.18%
ILMNIllumina Inc-1.87-1.06%
BIVVBioverativ Inc-0.44-0.76%
Data as of 3:59pm ET, 04/21/2017

Financials

Next reporting dateApril 27, 2017
EPS forecast (this quarter)$2.98
Annual revenue (last year)$22.7B
Annual profit (last year)$7.7B
Net profit margin34.04%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Robert A. Bradway
Executive Vice President-
Operations
Esteban Santos
Corporate headquarters
Thousand Oaks, California

Forecasts


Search for Jobs